MAP2K7 and familial pancreatic carcinoma: Recently, Jiang et al.37 reported that MEK and autophagy co-inhibition coupled with αCD40 invoked immune re-polarisation and was an attractive therapeutic approach for pancreatic cancer immunotherapy.